The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease.


Journal

Vascular pharmacology
ISSN: 1879-3649
Titre abrégé: Vascul Pharmacol
Pays: United States
ID NLM: 101130615

Informations de publication

Date de publication:
01 2019
Historique:
received: 01 06 2018
revised: 22 11 2018
accepted: 22 11 2018
pubmed: 7 12 2018
medline: 10 4 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

Noncoding RNAs (long noncoding RNAs and small RNAs) are emerging as critical modulators of phenotypic changes associated with physiological and pathological contexts in a variety of cardiovascular diseases (CVDs). Although it has been well established that hereditable genetic alterations and exposure to risk factors are crucial in the development of CVDs, other critical regulators of cell function impact on disease processes. Here we discuss noncoding RNAs have only recently been identified as key players involved in the progression of disease. In particular, we discuss micro RNA (miR)-143/145 since they represent one of the most characterised microRNA clusters regulating smooth muscle cell (SMC) differentiation and phenotypic switch in response to vascular injury and remodelling. MiR143HG is a well conserved long noncoding RNA (lncRNA), which is the host gene for miR-143/145 and recently implicated in cardiac specification during heart development. Although the lncRNA-miRNA interactions have not been completely characterised, their crosstalk is now beginning to emerge and likely requires further research focus. In this review we give an overview of the biology of the genomic axis that is miR-143/145 and MiR143HG, focusing on their important functional role(s) in the cardiovascular system.

Identifiants

pubmed: 30502421
pii: S1537-1891(18)30212-X
doi: 10.1016/j.vph.2018.11.006
pmc: PMC6395947
pii:
doi:

Substances chimiques

MIRN143 microRNA, human 0
MIRN145 microRNA, human 0
MicroRNAs 0
RNA, Long Noncoding 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-30

Subventions

Organisme : British Heart Foundation
ID : FS/18/10/33413
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/14/3/30706
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/12/9/29593
Pays : United Kingdom

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Science. 2001 Oct 26;294(5543):853-8
pubmed: 11679670
Nature. 2002 Dec 5;420(6915):563-73
pubmed: 12466851
J Biomech. 2003 May;36(5):681-8
pubmed: 12694998
Nature. 2003 Sep 25;425(6956):415-9
pubmed: 14508493
Nature. 2004 Mar 11;428(6979):185-9
pubmed: 15014501
Nature. 2004 Oct 21;431(7011):931-45
pubmed: 15496913
Science. 2005 Sep 2;309(5740):1559-63
pubmed: 16141072
Hypertension. 2006 Aug;48(2):180-6
pubmed: 16801490
Circ Res. 2007 Jun 8;100(11):1579-88
pubmed: 17478730
Science. 2007 Jun 8;316(5830):1484-8
pubmed: 17510325
Circ Res. 2008 Mar 28;102(6):661-8
pubmed: 18239137
Science. 2008 Mar 28;319(5871):1787-9
pubmed: 18369136
Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1505-10
pubmed: 18451334
Nature. 2008 Jul 3;454(7200):56-61
pubmed: 18548003
Nucleic Acids Res. 2009 Jan;37(Database issue):D122-6
pubmed: 18829717
Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39
pubmed: 19165215
Nature. 2009 Mar 12;458(7235):223-7
pubmed: 19182780
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Cell. 2009 May 15;137(4):647-58
pubmed: 19409607
Circ Res. 2009 Jul 17;105(2):158-66
pubmed: 19542014
Nature. 2009 Aug 6;460(7256):705-10
pubmed: 19578358
Cell Commun Signal. 2009 Aug 10;7:18
pubmed: 19664273
J Clin Invest. 2009 Sep;119(9):2634-47
pubmed: 19690389
Genes Dev. 2009 Sep 15;23(18):2166-78
pubmed: 19720868
Cell Death Differ. 2009 Dec;16(12):1590-8
pubmed: 19816508
Genome Res. 2010 Mar;20(3):381-92
pubmed: 20075146
Development. 2010 Jun;137(11):1887-96
pubmed: 20460367
Methods. 2010 Oct;52(2):150-8
pubmed: 20554050
Nat Rev Genet. 2010 Sep;11(9):597-610
pubmed: 20661255
Nature. 2010 Aug 12;466(7308):835-40
pubmed: 20703300
J Biochem. 2010 Oct;148(4):381-92
pubmed: 20833630
Mech Dev. 2011 Jan-Feb;128(1-2):18-28
pubmed: 20869435
Mol Cell. 2010 Oct 22;40(2):205-15
pubmed: 20965416
PLoS Genet. 2010 Dec 02;6(12):e1001233
pubmed: 21151960
Circ Cardiovasc Genet. 2011 Apr;4(2):197-205
pubmed: 21505201
J Biol Chem. 2011 Aug 12;286(32):28097-110
pubmed: 21673106
Bioinformatics. 2011 Jul 1;27(13):i275-82
pubmed: 21685081
J Biol Chem. 2011 Aug 12;286(32):28312-21
pubmed: 21685392
J Biol Chem. 2011 Aug 26;286(34):30119-29
pubmed: 21712382
Stroke. 2011 Sep;42(9):2556-63
pubmed: 21817153
Mol Cell. 2011 Sep 16;43(6):904-14
pubmed: 21925379
Nucleic Acids Res. 2012 Jan;40(Database issue):D1077-81
pubmed: 22064864
Nat Cell Biol. 2012 Feb 12;14(3):249-56
pubmed: 22327366
Circ Res. 2012 Jul 20;111(3):290-300
pubmed: 22715469
Circulation. 2012 Sep 11;126(11 Suppl 1):S81-90
pubmed: 22965997
Nat Cell Biol. 2013 Mar;15(3):284-94
pubmed: 23396050
Nat Protoc. 2013 May;8(5):849-69
pubmed: 23558785
Cardiovasc Res. 2013 Oct 1;100(1):7-18
pubmed: 23774505
Cell. 2013 Jul 3;154(1):26-46
pubmed: 23827673
Nucleic Acids Res. 2013 Sep;41(17):8220-36
pubmed: 23847102
RNA Biol. 2013 Oct;10(10):1631-43
pubmed: 24100239
Biochim Biophys Acta. 2014 Mar;1840(3):1063-71
pubmed: 24184936
PLoS One. 2013 Nov 15;8(11):e80345
pubmed: 24260372
Epigenetics. 2014 Jan;9(1):21-6
pubmed: 24335342
Circ Res. 2014 Jan 17;114(2):345-53
pubmed: 24436430
Nat Rev Genet. 2014 Mar;15(3):193-204
pubmed: 24514441
Eur Heart J. 2015 Feb 7;36(6):353-68a
pubmed: 24786300
Semin Cell Dev Biol. 2014 Oct;34:9-14
pubmed: 24965208
J Mol Cell Cardiol. 2014 Nov;76:55-70
pubmed: 25149110
Circ Res. 2015 Feb 13;116(4):751-62
pubmed: 25677521
Circ Res. 2015 May 22;116(11):1753-64
pubmed: 25801897
Circ Res. 2015 Oct 23;117(10):870-883
pubmed: 26311719
J Mol Cell Cardiol. 2015 Dec;89(Pt A):98-112
pubmed: 26423156
Nat Rev Genet. 2016 Jan;17(1):47-62
pubmed: 26666209
Clin Pharmacol Ther. 2016 May;99(5):494-501
pubmed: 26910520
J Am Coll Cardiol. 2016 Mar 15;67(10):1214-1226
pubmed: 26965544
Genomics Proteomics Bioinformatics. 2016 Apr;14(2):73-80
pubmed: 27163185
Trends Biochem Sci. 2016 Sep;41(9):761-772
pubmed: 27499234
Noncoding RNA Res. 2016 Oct;1(1):3-11
pubmed: 28090596
Circ Res. 2017 Jan 20;120(2):262-264
pubmed: 28104764
BMC Cardiovasc Disord. 2017 Jun 20;17(1):163
pubmed: 28633641
Nat Genet. 2017 Dec;49(12):1731-1740
pubmed: 29106417
Circ Res. 2018 Jan 5;122(1):155-166
pubmed: 29301847
Nature. 2018 Mar 1;555(7694):107-111
pubmed: 29466324
JACC Basic Transl Sci. 2016 Oct;1(6):472-493
pubmed: 29707678

Auteurs

Francesca Vacante (F)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.

Laura Denby (L)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.

Judith C Sluimer (JC)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK; Maastricht University Medical Centre, Dept. of Pathology, Maastricht 6229 HX, The Netherlands.

Andrew H Baker (AH)

Centre for Cardiovascular Science, The Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK. Electronic address: Andy.Baker@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH